MIR-324-5p suppresses hepatocellular carcinoma cell invasion by counteracting ECM degradation through post-transcriptionally downregulating ETS1 and SP1

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Cao, Liangqi ^a   Xie, Binhui ^b   Yang, Xuewei ^a   Liang, Huihong ^a   Jiang, Xiaofeng ^a   Zhang, Dawei ^a   Xue, Ping ^a   Chen, De ^a   Shao, Zili ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GANNAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MEMBRANE PROTEIN; MICRORNA; MICRORNA 324 5P; PROTEIN ETS1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; ETS1 PROTEIN, HUMAN; MIRN324 MICRORNA, HUMAN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; SMALL INTERFERING RNA; SP1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL INVASION; CELL MOTILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL MOTION; CHEMISTRY; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LIVER; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSFORMED CELL LINE; TUMOR CELL LINE; TUMOR INVASION;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; LIVER; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEIN C-ETS-1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84941370643     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133074     Document Type: Article

References (60)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90. doi: 10.3322/caac.20107 PMID: 21296855
2. Venook AP, Papandreou C, Furuse J, de Guevara LL (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15 Suppl 4: 5-13. doi: 10.1634/theoncologist.2010-S4-05 PMID: 21115576
3. Teo EK, Fock KM (2001) Hepatocellular carcinoma: an Asian perspective. Dig Dis 19: 263-268. PMID: 11935085
4. Jonas S, Bechstein WO, Steinmuller T, Herrmann M, Radke C, Berg T, et al. (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33: 1080-1086. PMID: 11343235
5. Thuluvath PJ (2009) Vascular invasion is the most important predictor of survival in HCC, but how do we find it? J Clin Gastroenterol 43: 101-102. doi: 10.1097/MCG.0b013e318191e64f PMID: 19142172
6. Sahai E (2005) Mechanisms of cancer cell invasion. Curr Opin Genet Dev 15: 87-96. PMID: 15661538
7. Kraljevic Pavelic S, Sedic M, Bosnjak H, Spaventi S, Pavelic K (2011) Metastasis: new perspectives on an old problem. Mol Cancer 10: 22. doi: 10.1186/1476-4598-10-22 PMID: 21342498
8. Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C (2004) Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48: 411-424. PMID: 15349816
9. Kondo S, Shukunami C, Morioka Y, Matsumoto N, Takahashi R, Oh J, et al. (2007) Dual effects of the membrane-Anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells. J Cell Sci 120: 849-857. PMID: 17298979
10. Bourboulia D, Stetler-StevensonWG (2010) Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20: 161-168. doi: 10.1016/j.semcancer.2010.05.002 PMID: 20470890
11. Kousidou OC, Roussidis AE, Theocharis AD, Karamanos NK (2004) Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential. Anticancer Res 24: 4025-4030. PMID: 15739263
12. Westermarck J, Kahari VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792. PMID: 10224222
13. Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, et al. (2006) Circulating MMP2 and MMP9 in breast cancer-potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer 119: 1403-1411. PMID: 16615109
14. Moroz A, Delella FK, Lacorte LM, Deffune E, Felisbino SL (2013) Fibronectin induces MMP2 expression in human prostate cancer cells. Biochem Biophys Res Commun 430: 1319-1321. doi: 10.1016/j. bbrc.2012.12.031 PMID: 23261429
15. Jacob A, Jing J, Lee J, Schedin P, Gilbert SM, Peden AA, et al. (2013) Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells. J Cell Sci 126: 4647-4658. doi: 10.1242/jcs.126573 PMID: 23902685
16. Fan HX, Li HX, Chen D, Gao ZX, Zheng JH (2012) Changes in the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implications. J Exp Clin Cancer Res 31: 90. doi: 10.1186/1756-9966-31-90 PMID: 23107277
17. Park KS, Kim SJ, Kim KH, Kim JC (2011) Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol 26: 391-397. doi: 10.1111/j.1440-1746. 2010.06504.x PMID: 21261731
18. Fromigue O, Hamidouche Z, Marie PJ (2008) Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J Biol Chem 283: 30549-30556. doi: 10.1074/jbc. M801436200 PMID: 18757369
19. Pazzaglia L, Ponticelli F, Magagnoli G, Magagnoli G, Gamberi G, Ragazzini P, et al. (2004) Activation of metalloproteinases-2 and-9 by interleukin-1alpha in S100A4-positive liposarcoma cell line: correlation with cell invasiveness. Anticancer Res 24: 967-972. PMID: 15161051
20. Chen R, Cui J, Xu C, Xue T, Guo K, Gao D, et al. (2012) The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection. Ann Surg Oncol 19 Suppl 3: S375-384. doi: 10.1245/s10434-011-1836-7 PMID: 21681378
21. Chen K, Zhang S, Ji Y, Li J, An P, Ren H, et al. (2013) Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway. PLoS One 8: e72927. doi: 10.1371/journal.pone.0072927 PMID: 24039823
22. Zhang J, Zhang DL, Jiao XL, Dong Q (2013) S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-kappaB-dependent MMP-9 signal. Eur Rev Med Pharmacol Sci 17: 2372-2382. PMID: 24065232
23. Chen D, Wang Y, Zhang K, Jiao X, Yan B, Liang J (2012) Antisense oligonucleotide against clusterin regulates human hepatocellular carcinoma invasion through transcriptional regulation of matrix metalloproteinase-2 and e-cadherin. Int J Mol Sci 13: 10594-10607. doi: 10.3390/ijms130810594 PMID: 22949882
24. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233. doi: 10. 1016/j.cell.2009.01.002 PMID: 19167326
25. Shukla GC, Singh J, Barik S (2011) MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. Mol Cell Pharmacol 3: 83-92. PMID: 22468167
26. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355. PMID: 15372042
27. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866. PMID: 17060945
28. Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591. doi: 10.1016/j.cell.2009.02.005 PMID: 19239879
29. Farazi TA, Hoell JI, Morozov P, Tuschl T (2013) MicroRNAs in human cancer. Adv Exp Med Biol 774: 1-20. doi: 10.1007/978-94-007-5590-1-1 PMID: 23377965
30. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, et al. (2008) Identification of metastasisrelated microRNAs in hepatocellular carcinoma. Hepatology 47: 897-907. doi: 10.1002/hep.22160 PMID: 18176954
31. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, et al. (2010) Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70: 9798-9807. doi: 10.1158/0008-5472.CAN-10-1001 PMID: 21098710
32. Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, et al. (2011) Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 29: 4781-4788. doi: 10.1200/JCO.2011.38.2697 PMID: 22105822
33. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, et al. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47: 1955-1963. doi: 10.1002/hep.22256 PMID: 18433021
34. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, et al. (2002) Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 22: 2111-2123. PMID: 11884599
35. Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852. doi: 10.1261/rna.939908 PMID: 18375788
36. Zhao W, Guo W, Zhou Q, Ma SN, Wang R, Qiu Y, et al. (2013) In Vitro Antimetastatic Effect of Phosphatidylinositol 3-Kinase Inhibitor ZSTK474 on Prostate Cancer PC3 Cells. Int J Mol Sci 14: 13577-13591. doi: 10.3390/ijms140713577 PMID: 23812078
37. Jiang L, Wu J, Yang Y, Liu L, Song L, Li J, et al. (2012) Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway. BMC Cancer 12: 406. doi: 10.1186/1471-2407-12-406 PMID: 22967049
38. Sementchenko VI, Watson DK (2000) Ets target genes: past, present and future. Oncogene 19: 6533-6548. PMID: 11175369
39. Shaikhibrahim Z, Wernert N (2012) ETS transcription factors and prostate cancer: the role of the family prototype ETS-1 (review). Int J Oncol 40: 1748-1754. doi: 10.3892/ijo.2012.1380 PMID: 22366814
40. Hahne JC, Okuducu AF, Kaminski A, Florin A, Soncin F, Wernert N (2005) Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth. Oncogene 24: 5384-5388. PMID: 15940256
41. Pande P, Mathur M, Shukla NK, Ralhan R (1999) Ets-1: a plausible marker of invasive potential and lymph node metastasis in human oral squamous cell carcinomas. J Pathol 189: 40-45. PMID: 10451486
42. Dittmer J (2003) The biology of the Ets1 proto-oncogene. Mol Cancer 2: 29. PMID: 12971829
43. Span PN, Manders P, Heuvel JJ, Thomas CM, Bosch RR, Beex LV, et al. (2002) Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene 21: 8506-8509. PMID: 12466970
44. Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I (2002) c-Ets1 is a promising marker in epithelial ovarian cancer. Int J Mol Med 9: 287-292. PMID: 11836635
45. Fujimoto J, Aoki I, Toyoki H, Khatun S, Tamaya T (2002) Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers. Ann Oncol 13: 1598-1604. PMID: 12377648
46. Ito Y, Miyoshi E, Takeda T, Sakon M, Noda K, Tsujimoto M, et al. (2000) Expression and possible role of ets-1 in hepatocellular carcinoma. Am J Clin Pathol 114: 719-725. PMID: 11068545
47. Calli AO, Sari A, Cakalagaoglu F, Altinboga AA, Oncel S (2011) ETS-1 proto-oncogene as a key newcomer molecule to predict invasiveness in laryngeal carcinoma. Pathol Res Pract 207: 628-633. doi: 10.1016/j.prp.2011.07.010 PMID: 21940109
48. Okuducu AF, Zils U, Michaelis SA, Michaelides S, von Deimling A (2006) Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas. Histopathology 48: 836-845. PMID: 16722933
49. Black AR, Black JD, Azizkhan-Clifford J (2001) Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188: 143-160. PMID: 11424081
50. Sankpal UT, Goodison S, Abdelrahim M, Basha R (2011) Targeting Sp1 transcription factors in prostate cancer therapy. Med Chem 7: 518-525. PMID: 22022994
51. Hsu TI, Wang MC, Chen SY, Yeh YM, Su WC, Chang WC, et al. (2012) Sp1 expression regulates lung tumor progression. Oncogene 31: 3973-3988. doi: 10.1038/onc.2011.568 PMID: 22158040
52. Guan H, Cai J, Zhang N, Wu J, Yuan J, Li J, et al. (2012) Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome. Int J Cancer 130: 593-601. doi: 10. 1002/ijc.26049 PMID: 21469139
53. Chang WC, Hung JJ (2012) Functional role of post-translational modifications of Sp1 in tumorigenesis. J Biomed Sci 19: 94. doi: 10.1186/1423-0127-19-94 PMID: 23148884
54. Jiang NY, Woda BA, Banner BF, Whalen GF, Dresser KA, Lu D (2008) Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 17: 1648-1652. doi: 10.1158/1055-9965.EPI-07-2791 PMID: 18628415
55. Naito S, Shimizu K, Nakashima M, Nakayama T, Ito T, Ito M, et al. (2000) Overexpression of Ets-1 transcription factor in angiosarcoma of the skin. Pathol Res Pract 196: 103-109. PMID: 10707367
56. Behrens P, Rothe M, Wellmann A, Krischler J, Wernert N (2001) The Ets-1 transcription factor is upregulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 194: 43-50. PMID: 11329140
57. Behrens P, Rothe M, Florin A, Wellmann A, Wernert N (2001) Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression. Int J Mol Med 8: 149-154. PMID: 11445865
58. Murthy S, Ryan AJ, Carter AB (2012) SP-1 regulation of MMP-9 expression requires Ser586 in the PEST domain. Biochem J 445: 229-236. doi: 10.1042/BJ20120053 PMID: 22519702
59. Zhou C, Ji J, Cai Q, Shi M, Chen X, Yu Y, et al. (2013) MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1. Mol Cancer 12: 102. doi: 10.1186/1476-4598-12-102 PMID: 24010737
60. Xia L, Zhang Y (2001) Sp1 and ETS family transcription factors regulate the mouse Mta2 gene expression. Gene 268: 77-85. PMID: 11368903